Incidence patterns of rare cancer in southeast Asian and western Pacific countries (RARECAREnet Asia project): a study using population-based cancer registry data, 2011–2015

IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES
Patumrat Sripan , Siti Norbayah Yusof , Donsuk Pongnikorn , Imjai Chitapanarux , Balqis Bahtiar , Nor Saleha Ibrahim Tamin , Karnchana Daoprasert , Narate Waisri , Young-Joo Won , RuRu Chun-Ju Chiang , Annalisa Trama , Hadrien Charvat , Kriengkrai Srithanaviboonchai , Tomohiro Matsuda
{"title":"Incidence patterns of rare cancer in southeast Asian and western Pacific countries (RARECAREnet Asia project): a study using population-based cancer registry data, 2011–2015","authors":"Patumrat Sripan ,&nbsp;Siti Norbayah Yusof ,&nbsp;Donsuk Pongnikorn ,&nbsp;Imjai Chitapanarux ,&nbsp;Balqis Bahtiar ,&nbsp;Nor Saleha Ibrahim Tamin ,&nbsp;Karnchana Daoprasert ,&nbsp;Narate Waisri ,&nbsp;Young-Joo Won ,&nbsp;RuRu Chun-Ju Chiang ,&nbsp;Annalisa Trama ,&nbsp;Hadrien Charvat ,&nbsp;Kriengkrai Srithanaviboonchai ,&nbsp;Tomohiro Matsuda","doi":"10.1016/j.lansea.2025.100670","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In Southeast Asia (SEA), the understanding of most rare cancers is limited, which sometimes leads to delays in diagnosis, treatment, and care. This study aimed to estimate for the first time the incidence of rare cancers in SEA using population-based cancer registry (PBCR) data from the 2011–2015 period.</div></div><div><h3>Methods</h3><div>This study used data from the nationwide PBCR of Malaysia and two PBCRs in northern Thailand in Chiang Mai and Lampang Cancer registries. The age-standardized incidence rate (ASR) per 100,000 person-year of the rare cancers included in the RARECAREnet list was calculated. All analyses were performed using SEER∗Stat (version 8.3.5). Cancers defined as rare by RARECAREnet in Europe were also rare in Thailand and Malaysia.</div></div><div><h3>Findings</h3><div>The ASR of some rare cancers in Thailand and Malaysia were greater than that in Japan, Korea, and Taiwan, including some pediatric cancers (pancreatoblastoma and odontogenic malignant tumors) in Malaysia, eye and adnexal cancer, and epithelial tumors of the penis in Thailand. ASR of nasopharyngeal cancer was higher in Thailand and Malaysia than in Japan and Korea but lower compared to Taiwan.</div></div><div><h3>Interpretation</h3><div>Although most rare cancers were also rare in Thailand and Malaysia, some cancers were not considered rare. However, the incidence of some rare cancers in Thailand and Malaysia were higher than that in Japan, Korea, and Taiwan. To enhance understanding, diagnosis, treatment, and care of rare cancers, reliable epidemiological data needs to be generated under the RARECAREnet Asia project by working with countries in Asia with high-quality PBCRs.</div></div><div><h3>Funding</h3><div>This study was supported by a <span>UICC Yamagiwa-Yoshida Memorial International Cancer</span> Study Grant (Award/Grant Number: <span><span>YY/2022-1477</span></span>) and <span>Government of Japan Ministry of Health Labour and Welfare</span> Grant numbers: <span><span>23EA1033</span></span>, and was partially supported by <span>Chiang Mai University</span>, Thailand.</div></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"41 ","pages":"Article 100670"},"PeriodicalIF":6.2000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet regional health. Southeast Asia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772368225001416","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

In Southeast Asia (SEA), the understanding of most rare cancers is limited, which sometimes leads to delays in diagnosis, treatment, and care. This study aimed to estimate for the first time the incidence of rare cancers in SEA using population-based cancer registry (PBCR) data from the 2011–2015 period.

Methods

This study used data from the nationwide PBCR of Malaysia and two PBCRs in northern Thailand in Chiang Mai and Lampang Cancer registries. The age-standardized incidence rate (ASR) per 100,000 person-year of the rare cancers included in the RARECAREnet list was calculated. All analyses were performed using SEER∗Stat (version 8.3.5). Cancers defined as rare by RARECAREnet in Europe were also rare in Thailand and Malaysia.

Findings

The ASR of some rare cancers in Thailand and Malaysia were greater than that in Japan, Korea, and Taiwan, including some pediatric cancers (pancreatoblastoma and odontogenic malignant tumors) in Malaysia, eye and adnexal cancer, and epithelial tumors of the penis in Thailand. ASR of nasopharyngeal cancer was higher in Thailand and Malaysia than in Japan and Korea but lower compared to Taiwan.

Interpretation

Although most rare cancers were also rare in Thailand and Malaysia, some cancers were not considered rare. However, the incidence of some rare cancers in Thailand and Malaysia were higher than that in Japan, Korea, and Taiwan. To enhance understanding, diagnosis, treatment, and care of rare cancers, reliable epidemiological data needs to be generated under the RARECAREnet Asia project by working with countries in Asia with high-quality PBCRs.

Funding

This study was supported by a UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant (Award/Grant Number: YY/2022-1477) and Government of Japan Ministry of Health Labour and Welfare Grant numbers: 23EA1033, and was partially supported by Chiang Mai University, Thailand.
东南亚和西太平洋国家罕见癌症发病率模式(RARECAREnet Asia项目):2011-2015年基于人群的癌症登记数据研究
在东南亚(SEA),对大多数罕见癌症的了解有限,这有时会导致诊断、治疗和护理的延误。本研究旨在利用2011-2015年期间基于人群的癌症登记(PBCR)数据首次估计东南亚地区罕见癌症的发病率。方法:本研究使用了马来西亚全国PBCR和泰国北部清迈和南邦癌症登记处的两个PBCR的数据。计算了RARECAREnet列表中包含的罕见癌症的每10万人年的年龄标准化发病率(ASR)。所有分析均使用SEER * Stat(8.3.5版)进行。在欧洲被RARECAREnet定义为罕见的癌症在泰国和马来西亚也很罕见。发现泰国和马来西亚的一些罕见癌症的ASR高于日本、韩国和台湾,包括马来西亚的一些儿科癌症(胰腺母细胞瘤和牙源性恶性肿瘤),泰国的眼睛和附件癌以及阴茎上皮肿瘤。泰国和马来西亚的鼻咽癌ASR高于日本和韩国,但低于台湾。虽然大多数罕见的癌症在泰国和马来西亚也很罕见,但有些癌症并不被认为是罕见的。然而,泰国和马来西亚的一些罕见癌症的发病率高于日本、韩国和台湾。为了加强对罕见癌症的了解、诊断、治疗和护理,需要通过与拥有高质量pbcr的亚洲国家合作,在RARECAREnet亚洲项目下生成可靠的流行病学数据。本研究由UICC yamagiawa - yoshida纪念国际癌症研究基金(奖励/资助号:YY/2022-1477)和日本厚生劳动省政府资助号:23EA1033支持,泰国清迈大学提供部分支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信